- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 24-38 of
1,041 results
No. 323
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 323 (E.D.Tex. Apr. 27, 2017)
|
|
Cite Document
No. 313
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 313 (E.D.Tex. Apr. 10, 2017)
|
|
Cite Document
No. 284
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 284 (E.D.Tex. Feb. 28, 2017)
|
|
Cite Document
147 Order: Canceling Oral Aargument
Document
IPR2016-01130, No. 147 Order - Canceling Oral Aargument (P.T.A.B. Jan. 7, 2019)
|
|
Cite Document
141 Order: ORDER Denying Request for Authorization to File Motion to Stay37 CFR...
Document
IPR2016-01130, No. 141 Order - ORDER Denying Request for Authorization to File Motion to Stay37 CFR 425 (P.T.A.B. Dec. 20, 2018)
|
|
Cite Document
141 Order: ORDER Denying Request for Authorization to File Motion to Stay37 CFR...
Document
IPR2016-01130, No. 141 Order - ORDER Denying Request for Authorization to File Motion to Stay37 CFR ¿¿ 425 (P.T.A.B. Dec. 20, 2018)
|
|
Cite Document
No. 265
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 265 (E.D.Tex. Jan. 26, 2017)
|
|
Cite Document
139 Order: Rescheduling the Date for Oral ArgumentAuthorizing Supplemental Bri...
Document
IPR2016-01130, No. 139 Order - Rescheduling the Date for Oral ArgumentAuthorizing Supplemental Briefing37 CFR 425 (P.T.A.B. Nov. 30, 2018)
|
|
Cite Document
139 Order: Rescheduling the Date for Oral ArgumentAuthorizing Supplemental Bri...
Document
IPR2016-01130, No. 139 Order - Rescheduling the Date for Oral ArgumentAuthorizing Supplemental Briefing37 CFR § 425 (P.T.A.B. Nov. 30, 2018)
|
|
Cite Document
No. 252
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 252 (E.D.Tex. Jan. 12, 2017)
|
|
Cite Document
No. 250
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 250 (E.D.Tex. Jan. 12, 2017)
|
|
Cite Document
No. 251
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 251 (E.D.Tex. Jan. 12, 2017)
|
|
Cite Document
No. 214
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 214 (E.D.Tex. Dec. 13, 2016)
|
|
Cite Document
No. 551
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 551 (E.D.Tex. Nov. 13, 2018)
|
|
Cite Document
No. 546
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 546 (E.D.Tex. Nov. 20, 2017)
|
|
Cite Document
